artemisinin

(redirected from Artemisinins)
Also found in: Medical.

ar·te·mis·i·nin

 (är′tə-mĭs′ĭ-nĭn)
n.
1. A compound, C15H22O5, that is obtained from a species of artemisia (Artemisia annua) and has antimalarial activity.
2. Any of several semisynthetic derivatives of this compound that are used to treat malaria, usually in combination with other drugs.

artemisinin

(ˌɑːtɪˈmɪzɪnɪn) pharmacol
n
a drug obtained from the plant genus Artemisia and used to treat malaria(as modifier)
Translations

artemisinin

n artemisinina
Mentioned in ?
References in periodicals archive ?
Globally, artemisinins are the mainstay of treatment.
Compassionate uses of artemisinins and Artemisia annua preparations for cancer therapy of veterinary and human tumors encouraged the performance of several clinical phase I/II trials (Berger et al.
Cultures were then resuspended in drug-free culture medium, and parasite counts were monitored microscopically daily until day 28 for sorbitol-treated or non-sorbitol-treated cultures exposed to artemisinins.
Radical measures will be necessary in Southeast Asia to prevent resistance to artemisinins and their partner drugs from spreading to the Indian subcontinent and then to Africa," said Dr.
One way to delay resistance is by offering artemisinins combined with other drugs.
day conference, political leaders, public health practitioners and members of civil society discussed key challenges in the region's fight against malaria, including emerging resistance to artemisinins, which are central to the efficacy of antimalarial treatment with artemisinin?
Artemisinins have also been shown to have anti-inflammatory [64,77] and antiproliferative effects against a wide range of cancer cell lines [28,65,30].
Another Nigerian study showed that chloroquine was mostly used for treating severe malaria from 2000-2006 in children less than 5 years despite recommendation by the National Treatment Policy (2005) [10] to switch over to quinine and parenteral artemisinins.
The use of oral Artemisinin based monotherapies threatens the therapeutic life of ACTs by fostering the spread of resistance to artemisinins.
is some early evidence that resistance to artemisinins may also be emerging on